​

Orchestra BioMed Ownership | Who Owns Orchestra BioMed?

OverviewRevenueFinancialsChart

Orchestra BioMed Ownership Summary

Orchestra BioMed is owned by 49.54% institutional investors, 21.93% insiders, and 28.53% retail investors. Millennium management is the largest institutional shareholder, holding 0% of OBIO shares.

OBIO Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockOrchestra BioMed49.54%21.93%28.53%
SectorHealthcare Stocks 279.19%10.62%-189.81%
IndustryBiotech Stocks 63.96%10.74%25.30%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Millennium management---
Russell investments group---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Millennium management---
Russell investments group---

Top Buyers

HolderShares% AssetsChange
Russell investments group---125.00
Millennium management---21.51K

Top Sellers

HolderShares% AssetsChange
Millennium management---21.51K
Russell investments group---125.00

Sold Out

HolderChange
Russell investments group-125.00
Millennium management-21.51K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2025548.00%18,940,1491.07%492.00%22-31.25%18157.14%
Dec 31, 20245210.64%19,199,4870.91%512.00%3425.93%7-22.22%
Sep 30, 2024472.17%19,025,94933.83%503.21%27-10.00%928.57%
Jun 30, 2024469.52%14,216,9936.62%392.86%3076.47%7-58.82%
Mar 31, 2024427.69%13,334,7300.49%372.34%17-15.00%17142.86%

Recent Insider Transactions

DateNameRoleActivityValue
Apr 30, 2025RTW INVESTMENTS, LP-Buy$149.20K
Apr 29, 2025RTW INVESTMENTS, LP-Buy$126.50K
Dec 23, 2024Hochman David P See RemarksBuy$18.64K
Dec 19, 2024Taylor Andrew Lawrence Chief Financial OfficerBuy$4.83K
Dec 18, 2024Hochman David P See RemarksBuy$24.55K

Insider Transactions Trends

DateBuySell
2025 Q22-
2025 Q1--
2024 Q43-
2024 Q368
2024 Q24-

OBIO Ownership FAQ

Who Owns Orchestra BioMed?

Orchestra BioMed shareholders are primarily institutional investors at 49.54%, followed by 21.93% insiders and 28.53% retail investors. The average institutional ownership in Orchestra BioMed's industry, Biotech Stocks , is 63.96%, which Orchestra BioMed falls below.

Does Blackrock own Orchestra BioMed?

BlackRock is not among the top 10 institutional shareholders of Orchestra BioMed.

Who is Orchestra BioMed’s biggest shareholder by percentage of total assets invested?

Millennium management is Orchestra BioMed’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Orchestra BioMed shares, valued at 0$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools